We are live on ! Find out more
CFM

Catalyst Funds Management Portfolio holdings

AUM $591M
1-Year Est. Return 71.09%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+71.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$455M
AUM Growth
+$82.4M
Cap. Flow
+$53.4M
Cap. Flow %
11.72%
Top 10 Hldgs %
38.61%
Holding
1,671
New
529
Increased
423
Reduced
135
Closed
403

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$38M
2
MSFT icon
Microsoft
MSFT
+$27.5M
3
LLY icon
Eli Lilly
LLY
+$12.9M
4
META icon
Meta Platforms (Facebook)
META
+$6.48M
5
DHR icon
Danaher
DHR
+$5.85M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$68.6M
2
AVGO icon
Broadcom
AVGO
+$17.9M
3
NU icon
Nu Holdings
NU
+$15.9M
4
DECK icon
Deckers Outdoor
DECK
+$7.58M
5
SMCI icon
Super Micro Computer
SMCI
+$6.23M

Sector Composition

Rank Sector Weight
1 Technology 21.89%
2 Healthcare 13.56%
3 Industrials 12.93%
4 Communication Services 11.23%
5 Financials 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKKT icon
1251
Bakkt Inc
BKKT
$336M
$3.83K ﹤0.01%
400
– –
CARM
1252
DELISTED
Carisma Therapeutics
CARM
$3.83K ﹤0.01%
3,900
– –
CUTR
1253
DELISTED
Cutera, Inc.
CUTR
$3.63K ﹤0.01%
4,600
– –
BYRN icon
1254
Byrna Technologies
BYRN
$87.6M
$3.39K ﹤0.01%
+200
New +$2.37K
ALDX icon
1255
Aldeyra Therapeutics
ALDX
$93.5M
$3.23K ﹤0.01%
+600
New +$2.86K
UONEK icon
1256
Urban One Class D
UONEK
$22.5M
$3.22K ﹤0.01%
290
– –
MRSN
1257
DELISTED
Mersana Therapeutics
MRSN
$3.21K ﹤0.01%
68
– –
ALMS
1258
Alumis Inc
ALMS
$3.5B
$3.2K ﹤0.01%
+300
New +$3.64K
BTAI icon
1259
BioXcel Therapeutics
BTAI
$27M
$3.17K ﹤0.01%
325
– –
PMVP icon
1260
PMV Pharmaceuticals
PMVP
$62.4M
$3.13K ﹤0.01%
2,100
– –
OFIX icon
1261
Orthofix Medical
OFIX
$481M
$3.12K ﹤0.01%
+200
New +$3.2K
XAIR icon
1262
Beyond Air
XAIR
$3.87M
$2.33K ﹤0.01%
15
– –
VTNR
1263
DELISTED
Vertex Energy, Inc
VTNR
$1.91K ﹤0.01%
16,500
– –
CNSL
1264
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$928 ﹤0.01%
+200
New +$909
ATRA icon
1265
Atara Biotherapeutics
ATRA
$70.2M
$813 ﹤0.01%
100
– –
TSBX
1266
DELISTED
Turnstone Biologics
TSBX
$446 ﹤0.01%
800
-3,100
-79% -$4.76K
IXHL icon
1267
Incannex Healthcare
IXHL
$35.9M
$100 ﹤0.01%
2
– –
GAU
1268
Galiano Gold
GAU
$481M
$10 ﹤0.01%
7
– –
AAPL icon
1269
Apple
AAPL
$4.93T
– –
-325,700
Closed -$68.6M
ACCO icon
1270
Acco Brands
ACCO
$381M
– –
-4,900
Closed -$23K
ACHR icon
1271
Archer Aviation
ACHR
$3.76B
– –
-37,200
Closed -$131K
ACIC icon
1272
American Coastal Insurance
ACIC
$504M
– –
-27,600
Closed -$291K
ADI icon
1273
Analog Devices
ADI
$181B
– –
-200
Closed -$45.7K
ADNT icon
1274
Adient
ADNT
$1.62B
– –
-600
Closed -$14.8K
AEP icon
1275
American Electric Power
AEP
$72.8B
– –
-100
Closed -$8.77K
49 50
51
52 53

Similar funds

BBL
Beck Bode LLC Dedham, Massachusetts $591M AUM 37.12% 1-Year Est. Return
BA
Bellwether Advisors Lincoln, Nebraska $590M AUM 35.66% 1-Year Est. Return
DPRC
Deer Park Road Corp Steamboat Springs, Colorado $591M AUM 27.7% 1-Year Est. Return
FL
Fourthstone LLC St Louis, Missouri $590M AUM 29.58% 1-Year Est. Return
MW
Maia Wealth Denver, Colorado $591M AUM 16.31% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
LBIM
Land & Buildings Investment Management Stamford, Connecticut $591M AUM 10.19% 1-Year Est. Return
MPW
MA Private Wealth San Carlos, California $591M AUM 16.05% 1-Year Est. Return

Catalyst Funds Management's Q3 2024 Portfolio in Review

As of Q3 2024, Catalyst Funds Management held 1,671 positions worth $455M, up 22% from $373M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Catalyst Funds Management deployed $53.4M of net new capital in Q3 2024, opening 529 new positions and adding to 423 existing holdings. Its largest new stake was Microsoft: 64,400 shares worth $27.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Broadcom, an estimated $17.9M trimmed.

  • Catalyst Funds Management's largest Q3 2024 buy was Microsoft: 64,400 shares worth $27.7M.
  • Catalyst Funds Management added most to NVIDIA in Q3 2024, an estimated $38M increase.
  • Catalyst Funds Management's biggest Q3 2024 reduction was Broadcom, cutting an estimated $17.9M.
  • Catalyst Funds Management fully exited Apple in Q3 2024, selling an estimated $68.6M.
  • Catalyst Funds Management's ten largest holdings make up 39% of its $455M portfolio in Q3 2024.
  • Catalyst Funds Management opened 529 new positions and closed 403 in Q3 2024.
  • Catalyst Funds Management's portfolio value rose 22% quarter-over-quarter to $455M.

Based on Catalyst Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.